Mayne Pharma Inc
Mayne Pharma Inc appears in FDA public data with 6 recalls, 0 510(k) clearances, 1 FDA inspection, and 0 compliance actions on record. Its most recent recall (D-1152-2022, Class II) was initiated on June 9, 2022.
Summary
- Total Recalls
- 6
- 510(k) Clearances
- 0
- Inspections
- 1
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-1152-2022 | Class II | Clonidine Transdermal System, USP 0.3 mg/day, 4 Patches (NDC 51862-455-01) per Carton (51862-455-04 | June 9, 2022 |
| D-0387-2022 | Class II | Lexette (halobetasol propionate) Topical Foam, 0.05% 50 g canisters, Rx ONLY, Distributed by: Mayne | January 14, 2022 |
| D-0998-2020 | Class II | Carbidopa and Levodopa Tablets, USP 25 mg/250mg, 100 ct bottle, Rx Only, Mayne Pharma, Greenville, N | March 2, 2020 |
| D-1129-2018 | Class III | Oxycodone and Acetaminophen Tablets, USP, 5 mg*/325 mg, 100-count bottle, Rx Only, Manufactured by: | August 21, 2018 |
| D-0616-2018 | Class III | Fabior (tazarotene) Foam, 0.1%, 100 grams can, Rx only, Distributed by: Mayne Pharma, Greenville, NC | March 21, 2018 |
| D-0098-2018 | Class II | Liothyronine Sodium Tablets, USP 25 mcg ,100-count bottles, Rx Only, Distributed by Perrigo Minneap | November 9, 2017 |